Global Cancer Ablation Devices Market Research Report 2021

1 Cancer Ablation Devices Market Overview

• 1.1 Product Overview and Scope of Cancer Ablation Devices
• 1.2 Cancer Ablation Devices Segment by Type
  • 1.2.1 Global Cancer Ablation Devices Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Cryoablation
  • 1.2.3 High-Intensity Focused Ultrasound (HIFU)
  • 1.2.4 Laser Interstitial Thermal Therapy (LiTT)
  • 1.2.5 Microwave Ablation (MWA)
  • 1.2.6 Radiofrequency Ablation (RFA)
  • 1.2.7 Irreversible Electroporation (Ire)
  • 1.2.8 Non-Thermal Ablation
• 1.3 Cancer Ablation Devices Segment by Application
  • 1.3.1 Cancer Ablation Devices Sales Comparison by Application: (2021-2027)
  • 1.3.2 Brain Cancer
  • 1.3.3 Brown
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Kidney Cancer
  • 1.3.6 Liver Cancer
  • 1.3.7 Lung Cancer
  • 1.3.8 Pancreatic Cancer
  • 1.3.9 Prostate Cancer
• 1.4 Global Cancer Ablation Devices Market Size Estimates and Forecasts
  • 1.4.1 Global Cancer Ablation Devices Revenue 2016-2027
  • 1.4.2 Global Cancer Ablation Devices Sales 2016-2027
  • 1.4.3 Cancer Ablation Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cancer Ablation Devices Market Competition by Manufacturers

• 2.1 Global Cancer Ablation Devices Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Cancer Ablation Devices Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Cancer Ablation Devices Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Cancer Ablation Devices Manufacturing Sites, Area Served, Product Type
• 2.5 Cancer Ablation Devices Market Competitive Situation and Trends
  • 2.5.1 Cancer Ablation Devices Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Cancer Ablation Devices Players Market Share by Revenue
  • 2.5.3 Global Cancer Ablation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cancer Ablation Devices Retrospective Market Scenario by Region

• 3.1 Global Cancer Ablation Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Cancer Ablation Devices Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Cancer Ablation Devices Market Facts & Figures by Country
  • 3.3.1 North America Cancer Ablation Devices Sales by Country
  • 3.3.2 North America Cancer Ablation Devices Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Cancer Ablation Devices Market Facts & Figures by Country
  • 3.4.1 Europe Cancer Ablation Devices Sales by Country
  • 3.4.2 Europe Cancer Ablation Devices Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Cancer Ablation Devices Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Cancer Ablation Devices Sales by Region
  • 3.5.2 Asia Pacific Cancer Ablation Devices Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Cancer Ablation Devices Market Facts & Figures by Country
  • 3.6.1 Latin America Cancer Ablation Devices Sales by Country
  • 3.6.2 Latin America Cancer Ablation Devices Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Cancer Ablation Devices Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Cancer Ablation Devices Sales by Country
  • 3.7.2 Middle East and Africa Cancer Ablation Devices Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Cancer Ablation Devices Historic Market Analysis by Type

• 4.1 Global Cancer Ablation Devices Sales Market Share by Type (2016-2021)
• 4.2 Global Cancer Ablation Devices Revenue Market Share by Type (2016-2021)
• 4.3 Global Cancer Ablation Devices Price by Type (2016-2021)

5 Global Cancer Ablation Devices Historic Market Analysis by Application

• 5.1 Global Cancer Ablation Devices Sales Market Share by Application (2016-2021)
• 5.2 Global Cancer Ablation Devices Revenue Market Share by Application (2016-2021)
• 5.3 Global Cancer Ablation Devices Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Alfresa Pharma Corp.
  • 6.1.1 Alfresa Pharma Corp. Corporation Information
  • 6.1.2 Alfresa Pharma Corp. Description and Business Overview
  • 6.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Alfresa Pharma Corp. Product Portfolio
  • 6.1.5 Alfresa Pharma Corp. Recent Developments/Updates
• 6.2 AngioDynamics, Inc.
  • 6.2.1 AngioDynamics, Inc. Corporation Information
  • 6.2.2 AngioDynamics, Inc. Description and Business Overview
  • 6.2.3 AngioDynamics, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 AngioDynamics, Inc. Product Portfolio
  • 6.2.5 AngioDynamics, Inc. Recent Developments/Updates
• 6.3 BTG plc (Galil Medical Ltd./Perseon Medical)
  • 6.3.1 BTG plc (Galil Medical Ltd./Perseon Medical) Corporation Information
  • 6.3.2 BTG plc (Galil Medical Ltd./Perseon Medical) Description and Business Overview
  • 6.3.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 BTG plc (Galil Medical Ltd./Perseon Medical) Product Portfolio
  • 6.3.5 BTG plc (Galil Medical Ltd./Perseon Medical) Recent Developments/Updates
• 6.4 Biomedical S.r.l.
  • 6.4.1 Biomedical S.r.l. Corporation Information
  • 6.4.2 Biomedical S.r.l. Description and Business Overview
  • 6.4.3 Biomedical S.r.l. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Biomedical S.r.l. Product Portfolio
  • 6.4.5 Biomedical S.r.l. Recent Developments/Updates
• 6.5 Boston Scientific Corporation
  • 6.5.1 Boston Scientific Corporation Corporation Information
  • 6.5.2 Boston Scientific Corporation Description and Business Overview
  • 6.5.3 Boston Scientific Corporation Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Boston Scientific Corporation Product Portfolio
  • 6.5.5 Boston Scientific Corporation Recent Developments/Updates
• 6.6 CSA Medical, Inc.
  • 6.6.1 CSA Medical, Inc. Corporation Information
  • 6.6.2 CSA Medical, Inc. Description and Business Overview
  • 6.6.3 CSA Medical, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 CSA Medical, Inc. Product Portfolio
  • 6.6.5 CSA Medical, Inc. Recent Developments/Updates
• 6.7 Chongqing Haifu Medical Technology Co., Ltd
  • 6.6.1 Chongqing Haifu Medical Technology Co., Ltd Corporation Information
  • 6.6.2 Chongqing Haifu Medical Technology Co., Ltd Description and Business Overview
  • 6.6.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Chongqing Haifu Medical Technology Co., Ltd Product Portfolio
  • 6.7.5 Chongqing Haifu Medical Technology Co., Ltd Recent Developments/Updates
• 6.8 ECO Medical
  • 6.8.1 ECO Medical Corporation Information
  • 6.8.2 ECO Medical Description and Business Overview
  • 6.8.3 ECO Medical Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 ECO Medical Product Portfolio
  • 6.8.5 ECO Medical Recent Developments/Updates
• 6.9 EDAP TMS S.A.
  • 6.9.1 EDAP TMS S.A. Corporation Information
  • 6.9.2 EDAP TMS S.A. Description and Business Overview
  • 6.9.3 EDAP TMS S.A. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 EDAP TMS S.A. Product Portfolio
  • 6.9.5 EDAP TMS S.A. Recent Developments/Updates
• 6.10 HS Hospital Service S.p.A.
  • 6.10.1 HS Hospital Service S.p.A. Corporation Information
  • 6.10.2 HS Hospital Service S.p.A. Description and Business Overview
  • 6.10.3 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 HS Hospital Service S.p.A. Product Portfolio
  • 6.10.5 HS Hospital Service S.p.A. Recent Developments/Updates
• 6.11 IceCure Medical, Inc.
  • 6.11.1 IceCure Medical, Inc. Corporation Information
  • 6.11.2 IceCure Medical, Inc. Cancer Ablation Devices Description and Business Overview
  • 6.11.3 IceCure Medical, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 IceCure Medical, Inc. Product Portfolio
  • 6.11.5 IceCure Medical, Inc. Recent Developments/Updates
• 6.12 Johnson & Johnson (Ethicon, Inc.)
  • 6.12.1 Johnson & Johnson (Ethicon, Inc.) Corporation Information
  • 6.12.2 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Description and Business Overview
  • 6.12.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Johnson & Johnson (Ethicon, Inc.) Product Portfolio
  • 6.12.5 Johnson & Johnson (Ethicon, Inc.) Recent Developments/Updates
• 6.13 Kang-Yu Medical Co., Ltd.
  • 6.13.1 Kang-Yu Medical Co., Ltd. Corporation Information
  • 6.13.2 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Description and Business Overview
  • 6.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Kang-Yu Medical Co., Ltd. Product Portfolio
  • 6.13.5 Kang-Yu Medical Co., Ltd. Recent Developments/Updates
• 6.14 MedLink Technologies LLC
  • 6.14.1 MedLink Technologies LLC Corporation Information
  • 6.14.2 MedLink Technologies LLC Cancer Ablation Devices Description and Business Overview
  • 6.14.3 MedLink Technologies LLC Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 MedLink Technologies LLC Product Portfolio
  • 6.14.5 MedLink Technologies LLC Recent Developments/Updates
• 6.15 MedWaves, Inc.
  • 6.15.1 MedWaves, Inc. Corporation Information
  • 6.15.2 MedWaves, Inc. Cancer Ablation Devices Description and Business Overview
  • 6.15.3 MedWaves, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 MedWaves, Inc. Product Portfolio
  • 6.15.5 MedWaves, Inc. Recent Developments/Updates

7 Cancer Ablation Devices Manufacturing Cost Analysis

• 7.1 Cancer Ablation Devices Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Cancer Ablation Devices
• 7.4 Cancer Ablation Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Cancer Ablation Devices Distributors List
• 8.3 Cancer Ablation Devices Customers

9 Cancer Ablation Devices Market Dynamics

• 9.1 Cancer Ablation Devices Industry Trends
• 9.2 Cancer Ablation Devices Growth Drivers
• 9.3 Cancer Ablation Devices Market Challenges
• 9.4 Cancer Ablation Devices Market Restraints

10 Global Market Forecast

• 10.1 Cancer Ablation Devices Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Cancer Ablation Devices by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Cancer Ablation Devices by Type (2022-2027)
• 10.2 Cancer Ablation Devices Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Cancer Ablation Devices by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Cancer Ablation Devices by Application (2022-2027)
• 10.3 Cancer Ablation Devices Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Cancer Ablation Devices by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Cancer Ablation Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List